Goldman's double upgrade is a high-conviction contrarian call, but the heavy insider selling and 58% short interest create a tug-of-war. Aggressive traders can use the $355 level as a pivot, a break above $360 with volume could trigger a short squeeze; failure to hold $340 would negate the bullish thesis.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 6 $421.23entry
- T+1 · 6mo ago −3.13%α −2.80% · $408.03
- T+5 · 6mo ago +6.43%α +5.29% · $448.29
- T+20 · 6mo ago +28.80%α +26.01% · $542.52
- T+60 · 4mo ago +15.23%α +14.16% · $485.39
Price Chart
How similar events traded
Executive Summary
Goldman Sachs issued a rare double upgrade from Neutral to Buy on May 6, 2026, slashing a new price target of $450 versus the prior $240, an 88% increase. The stock currently trades at $355.26, implying 27% upside to the new target. Goldman's accuracy on this name is 67% (2 of 3 calls), above the average firm. The consensus is heavily bullish at 67% Buy/Strong Buy, but the mean target is just $312.28, meaning Goldman's new PT is 44% above consensus and the highest on the Street. EPS revisions are trending sharply higher: 30-day revisions up 14 vs 2 down for the current fiscal year. However, insider selling is heavy, $24M in sales by the CFO in April alone, and short interest is elevated at 58.3% of float. The double upgrade from a top-tier firm with a contrarian price target is a powerful signal, but the insider and short data create a divergence that warrants caution. Bottom line: this is a high-conviction call from a credible source, but traders should watch for confirmation from price action given the conflicting signals.
Impact Score
Consensus & Targets
The consensus among 59 analysts is 76% Buy/Strong Buy (45 of 59), 22% Hold (13), and 2% Sell (1). The direction is overwhelmingly bullish, but Goldman's new target is far above the mean, making this a contrarian call within a bullish consensus.
Current price: $355.26. Mean target: $312.28 (12% downside). Median: $305 (14% downside). High: $455 (28% upside). Low: $225 (37% downside). Goldman's $450 target is the second-highest on the Street, 44% above the mean and 48% above the median.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-06 | Goldman Sachs | upgrade | Buy | $450.00 |
| 2026-05-04 | HSBC | downgrade | Hold | $340.00 |
| 2026-05-04 | Wedbush | maintain | Outperform | $400.00 |
| 2026-05-01 | RBC Capital | maintain | Sector Perform | $325.00 |
| 2026-04-29 | Susquehanna | maintain | Positive | $375.00 |
| 2026-04-27 | Northland Capital Markets | downgrade | Market Perform | $260.00 |
| 2026-04-24 | DA Davidson | upgrade | Buy | No target |
| 2026-04-20 | Stifel | maintain | Buy | $320.00 |
| 2026-04-16 | Bernstein | maintain | Market Perform | $265.00 |
| 2026-04-06 | Citigroup | maintain | Neutral | $248.00 |
30-day analyst activity: 2 upgrades (Goldman Sachs, DA Davidson) and 2 downgrades (HSBC, Northland Capital). EPS revisions are strongly positive: 30-day revisions up 14 vs 2 down for the current fiscal year, and up 10 vs 4 down for the current quarter. Estimates are being revised higher across all periods.
Firm Track Record: Goldman Sachs
Goldman Sachs accuracy: 54% on 2921 calls | avg return: 5.6%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Bernstein | 100% | 2/2 | 65.5% | top tier |
| Raymond James | 100% | 2/2 | 58.8% | top tier |
| Melius Research | 100% | 3/3 | 8.3% | top tier |
| Wolfe Research | 100% | 2/2 | -11.5% | top tier |
| HSBC | 83% | 5/6 | 17.6% | top tier |
| Barclays | 71% | 5/7 | 21.8% | top tier |
| Goldman Sachs | 67% | 2/3 | 4.1% | top tier |
| Stifel | 60% | 3/5 | 25.5% | above average |
| Mizuho | 57% | 8/14 | 12.3% | above average |
| B of A Securities | 55% | 6/11 | 21% | above average |
Goldman Sachs has a 67% accuracy rate on this stock (2 of 3 calls) with an average return of 4.1%, ranking as a top-tier firm. The best performing firms are Bernstein, Raymond James, and Melius Research (all 100% accuracy on 2-3 calls). The worst are Evercore ISI and Benchmark (44% accuracy on 9 calls each).
Earnings Estimates
Next earnings: Aug 3, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $1.44 | $1.26 to $1.71 | $10.5B | ↑3 ↓0 |
| +1y | $11.22 | $7.40 to $14.26 | $69.0B | ↑2 ↓0 |
| +1q | $1.71 | $1.39 to $2.05 | $11.9B | ↑3 ↓0 |
| 0y | $6.76 | $5.60 to $7.95 | $46.9B | ↑3 ↓0 |
Cross-Platform Signals
Insider trading is heavily bearish: CFO Mark Papermaster sold $24M in stock over three weeks in April. Congressional activity is mixed (2 small sells, 1 small buy). Institutional moves are mixed: Norges Bank added a massive new $4.9B position, FMR added 63%, but Bank of America and Wells Fargo trimmed 38% and 45% respectively. Short interest is very high at 58.3% of float, indicating significant bearish positioning. This diverges sharply from the bullish analyst signal.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
46 reports on AMD
10 of 16 bullish or bearish reports moved the stock their way by T+5. Best: +44.80% at T+60 after the Apr 24, 2026 report. 13 of 16 went positive at some point.
Filters
- Nov 16, 2026today 144 Neutral 3/10 Entry $504.60 Now $504.28 −0.06% settles Nov 24
- Nov 16, 2026today 8-K/A Neutral 3/10 Entry $506.51 Now $504.28 −0.44% settles Nov 23
- Nov 16, 2026today Press Release Neutral 4/10 Entry $507.11 Now $504.28 −0.56% settles Nov 23
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $585.30 Now $504.28 −13.84% settles Nov 19
- Nov 3, 202613d ago 8-K Bullish 7/10 No price data
- Nov 3, 202613d ago Press Release Bullish 7/10 Entry $488.78 to $552.90 Now $504.28 +3.17% ▲ +13.12% +14.03% vs SPY
- Oct 27, 202620d ago Press Release Bullish 6/10 Entry $560.26 to $483.90 Now $504.28 −9.99% ▼ −13.63% −11.64% vs SPY
- Oct 22, 202624d ago Institutional Cluster Mixed 3/10 Entry $516.79 to $504.80 Now $504.28 −2.42% ▼ −2.32% −1.76% vs SPY
- Oct 21, 202627d ago PTAB Trial Neutral 3/10 Entry $507.93 to $562.50 Now $504.28 −0.72% ▲ +10.74% +10.04% vs SPY
- Oct 20, 202628d ago PTAB Trial Bullish 5/10 Entry $552.72 to $560.26 Now $504.28 −8.76% ▲ +1.36% +1.47% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers